Igen International v. Roche Holding AG

In a jury verdict out of the U.S. District Court in Maryland, Igen International was awarded damages stemming from several contract-related disputes between itself and Roche Holding AG. The underlying technology at issue permitted the detection and measurement of biological substances and was incorporated into a variety of instrument systems and related consumable agents. Analysis Group Managing Principal John Jarosz testified that the appropriate amount of compensatory damages was in the range of $95 million to $120 million. Igen's expert testified that the amount was roughly $700 million. The jury awarded $105 million in compensatory damages. It also awarded punitive damages of $400 million.

Analysis Group's work was directed by Managing Principal Christopher Borek and Principal Robert Vigil. Among other things, we examined the pace of technological change in the industry, the period of likely damages impact, Roche's own contributions, and the nature and strength of competing systems. We worked alongside the law firm of Foley & Lardner.